Literature DB >> 30539418

ATP Synthase Subunit Beta Immunostaining is Reduced in the Sclerotic Hippocampus of Epilepsy Patients.

Marcelo Vilas Boas Mota1, Bruna Cunha Zaidan1, Amanda Morato do Canto2, Enrico Ghizoni3, Helder Tedeschi3, Luciano de Souza Queiroz1, Marina K M Alvim3, Fernando Cendes3, Iscia Lopes-Cendes2, André Almeida Schenka4, André Schwambach Vieira5, Fabio Rogerio6.   

Abstract

Epilepsy is a common disease presenting with recurrent seizures. Hippocampal sclerosis (HS) is the commonest histopathological alteration in patients with temporal lobe epilepsy (TLE) undergoing surgery. HS physiopathogenesis is debatable. We have recently studied, by using mass spectrometry-based proteomics, an experimental model of TLE induced by electrical stimulation. Specifically, protein expressions of both the beta subunit of mitochondrial ATP synthase (ATP5B) and of membrane ATPases were found to be reduced. Here, we investigated tissue distribution of ATP5B and sodium/potassium-transporting ATPase subunit alpha-3 (NKAα3), a protein associated with neuromuscular excitability disorders, in human hippocampi resected "en bloc" for HS treatment (n = 15). We used immunohistochemistry and the stained area was digitally evaluated (increase in binary contrast of microscopic fields) in the hippocampal sectors (CA1-CA4) and dentate gyrus. All HS samples were classified as Type 1, according to the International League Against Epilepsy (ILAE) 2013 Classification (predominant cell loss in CA1 and CA4). ATP5B was significantly decreased in all sectors and dentate gyrus of HS patients compared with individuals submitted to necropsy and without history of neurological alterations (n = 10). NKAα3 expression showed no difference. Moreover, we identified a negative correlation between frequency of pre-operative seizures and number of neurons in CA1. In conclusion, our data showed similarity between changes in protein expression in a model of TLE and individuals with HS. ATP5B reduction would be at least in part due to neuronal loss. Future investigations on ATP5B activity could provide insights into the process of such cell loss.

Entities:  

Keywords:  Epilepsy; Hippocampal sclerosis; Immunohistochemistry; Mitochondrial ATP synthase; Proteomics; Sodium/potassium ATPase

Mesh:

Substances:

Year:  2018        PMID: 30539418     DOI: 10.1007/s10571-018-0641-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  17 in total

1.  Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region.

Authors:  Cyrille Vaillend; Susanne E Mason; Matthew F Cuttle; Bradley E Alger
Journal:  J Neurophysiol       Date:  2002-12       Impact factor: 2.714

Review 2.  The role of mitochondria in neurodegenerative diseases.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Valeria Gregorelli; Paola Tonin; Giuliano Tomelleri; Alessandro Padovani
Journal:  J Neurol       Date:  2011-05-22       Impact factor: 4.849

3.  Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.

Authors:  Kimmo J Hatanpaa; Jack M Raisanen; Emily Herndon; Dennis K Burns; Chan Foong; Amyn A Habib; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

4.  The expanding clinical and genetic spectrum of ATP1A3-related disorders.

Authors:  Hendrik Rosewich; Andreas Ohlenbusch; Peter Huppke; Lars Schlotawa; Martina Baethmann; Inês Carrilho; Simona Fiori; Charles Marques Lourenço; Sarah Sawyer; Robert Steinfeld; Jutta Gärtner; Knut Brockmann
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

5.  Classic hippocampal sclerosis and hippocampal-onset epilepsy produced by a single "cryptic" episode of focal hippocampal excitation in awake rats.

Authors:  Braxton A Norwood; Argyle V Bumanglag; Francesco Osculati; Andrea Sbarbati; Pasquina Marzola; Elena Nicolato; Paolo F Fabene; Robert S Sloviter
Journal:  J Comp Neurol       Date:  2010-08-15       Impact factor: 3.215

6.  Changes in intracellular protein expression in cortex, thalamus and hippocampus in a genetic rat model of absence epilepsy.

Authors:  Ozkan Danış; Serap Demir; Aslıhan Günel; Rezzan Gülhan Aker; Medine Gülçebi; Filiz Onat; Ayşe Ogan
Journal:  Brain Res Bull       Date:  2011-02-15       Impact factor: 4.077

Review 7.  Neuronal function and alpha3 isoform of the Na/K-ATPase.

Authors:  Maxim Dobretsov; Joseph R Stimers
Journal:  Front Biosci       Date:  2005-09-01

8.  Selective vulnerability of hippocampal cornu ammonis 1 pyramidal cells to excitotoxic insult is associated with the expression of polyamine-sensitive N-methyl-D-asparate-type glutamate receptors.

Authors:  T R Butler; R L Self; K J Smith; L J Sharrett-Field; J N Berry; J M Littleton; J R Pauly; P J Mulholland; M A Prendergast
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

9.  A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet.

Authors:  Hae Sook Noh; Hee Po Lee; Dong Wook Kim; Sang Soo Kang; Gyeong Jae Cho; Jong M Rho; Wan Sung Choi
Journal:  Brain Res Mol Brain Res       Date:  2004-10-22

10.  International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Fabrice Bartolomei; Andrea Bernasconi; Neda Bernasconi; Christian G Bien; Fernando Cendes; Roland Coras; J Helen Cross; Thomas S Jacques; Philippe Kahane; Gary W Mathern; Haijme Miyata; Solomon L Moshé; Buge Oz; Çiğdem Özkara; Emilio Perucca; Sanjay Sisodiya; Samuel Wiebe; Roberto Spreafico
Journal:  Epilepsia       Date:  2013-05-20       Impact factor: 5.864

View more
  4 in total

1.  Differential DNA Methylation Profiles in Patients with Temporal Lobe Epilepsy and Hippocampal Sclerosis ILAE Type I.

Authors:  Wang Zhang; Haiyang Wang; Binchao Liu; Miaomiao Jiang; Yifei Gu; Shi Yan; Xian Han; Alicia Y Hou; Chongyang Tang; Zhenfeng Jiang; Hong Shen; Meng Na; Zhiguo Lin
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

Review 2.  Neuroproteomics in Epilepsy: What Do We Know so Far?

Authors:  Amanda M do Canto; Amanda Donatti; Jaqueline C Geraldis; Alexandre B Godoi; Douglas C da Rosa; Iscia Lopes-Cendes
Journal:  Front Mol Neurosci       Date:  2021-01-07       Impact factor: 5.639

3.  Histopathological Correlations of Qualitative and Quantitative Temporopolar MRI Analyses in Patients With Hippocampal Sclerosis.

Authors:  Bruna Cunha Zaidan; Ingrid Carolina da Silva Cardoso; Brunno Machado de Campos; Luciana Ramalho Pimentel da Silva; Vanessa C Mendes Coelho; Kairo Alexandre Alves Silveira; Bárbara Juarez Amorim; Marina Koutsodontis Machado Alvim; Helder Tedeschi; Clarissa Lin Yasuda; Enrico Ghizoni; Fernando Cendes; Fabio Rogerio
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

4.  Benchmarking the proteomic profile of animal models of mesial temporal epilepsy.

Authors:  Amanda M Canto; Alexandre B Godoi; Alexandre H B Matos; Jaqueline C Geraldis; Fabio Rogerio; Marina K M Alvim; Clarissa L Yasuda; Enrico Ghizoni; Helder Tedeschi; Diogo F T Veiga; Barbara Henning; Welliton Souza; Cristiane S Rocha; André S Vieira; Elayne V Dias; Benilton S Carvalho; Rovilson Gilioli; Albert B Arul; Renã A S Robinson; Fernando Cendes; Iscia Lopes-Cendes
Journal:  Ann Clin Transl Neurol       Date:  2022-03-03       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.